NDC 63323-193 – Irinotecan Hydrochloride
Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Intravenous
Product NDC63323-193
Product details
- Brand name
- Irinotecan Hydrochloride
- Generic name
- Irinotecan Hydrochloride
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA077776
- Marketed since
- April 1, 2009
- Listing expires
- December 31, 2026
- Pharmacologic class
- Topoisomerase Inhibitor
Active ingredients
- Irinotecan Hydrochloride 20 mg/mL
Uses, dosage, side effects and warnings for Irinotecan Hydrochloride →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 63323-193-52 | 1 VIAL in 1 BOX (63323-193-52) / 2 mL in 1 VIAL | Apr 1, 2009 |
| 63323-193-55 | 1 VIAL in 1 BOX (63323-193-55) / 5 mL in 1 VIAL | Apr 1, 2009 |
Recalls mentioning this NDC
- D-915-2013 Aug 28, 2013 · Class II
Crystallization: Active pharmaceutical ingredient is precipitating in product solution.
Other Irinotecan Hydrochloride products
- 45963-614 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Actavis Pharma, Inc.
- 60505-6272 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Apotex Corp.
- 60505-6128 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Apotex Corp.
- 55150-352 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 55150-353 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 55150-354 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 55150-355 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 61703-349 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Hospira, Inc.
- 67184-0513 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Qilu Pharmaceutical Co., Ltd.
- 67184-0512 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Qilu Pharmaceutical Co., Ltd.
- 67184-0511 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Qilu Pharmaceutical Co., Ltd.
- 25021-230 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Sagent Pharmaceuticals